Finzati - Logo
FATE logo

Fate Therapeutics, Inc.

FATE • Biotechnology
Strong market move
FATE+10.75%
vs. previous close $1.86
$2.06
▲ +0.20 (+10.75%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$248.02M
Growth
-5.9%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.38Healthy liquidity · 5.79Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:15 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.06
Change10.75%
Shares Out120.40M
Market Cap$248.02M
Enterprise Value$94.25M
52W Range0.93 - 3.23
Beta2.53
P/E-1.97
P/S38.21
P/B1.62
P/FCF-2.35
EV/Sales14.52

Investment DNA

How strong this company looks for long-term investors

35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0.38Healthy liquidity · 5.79Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

FATE
Analyst sentiment
Based on 31 analyst votes · 2026-10-21
73/100
Bullish
Bullish
16
Hold
13
Bearish
2
Price Target
2026-08-14
Low
$4.00
Mean
$5.50
Median
$5.50
High
$7.00

Company Overview

IPO: 10/1/2013
Industry: Biotechnology
P/B i: 1.62
Debt / Equity i: 0.38
Operating Margin: -2222.45%
Net Margin: -2051.08%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.38
Current Ratio: 5.79
Quick Ratio: 5.79
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Valamehr Bahram
Transaction: 08/04/2026
SELL
Change
-43,947
Price
$2.46
Filing
08/05/2026
Type
SELL
TAHL CINDY
Transaction: 08/04/2026
SELL
Change
-38,800
Price
$2.46
Filing
08/05/2026
Type
SELL
Hamill Laura
Transaction: 06/12/2026
OTHER
Change
0
Price
Not reported
Filing
06/15/2026
Type
OTHER